MARKET

PBM

PBM

Psyence Biomedical Ltd.
NASDAQ
1.480
-0.100
-6.33%
After Hours: 1.480 0 0.00% 19:53 12/15 EST
OPEN
1.480
PREV CLOSE
1.580
HIGH
1.550
LOW
1.460
VOLUME
232.79K
TURNOVER
--
52 WEEK HIGH
62.72
52 WEEK LOW
1.410
MARKET CAP
2.77M
P/E (TTM)
-2.9111
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBM last week (1208-1212)?
Weekly Report · 1d ago
Psyence Biomedical CEO says 2025 was a ‘turning point’ for company
TipRanks · 12/09 12:26
Psyence BioMed Reports Phase IIb Trial Progress and Strengthened Cash Position
Reuters · 12/09 12:02
Weekly Report: what happened at PBM last week (1201-1205)?
Weekly Report · 12/08 10:32
Weekly Report: what happened at PBM last week (1124-1128)?
Weekly Report · 12/01 10:27
Psyence Biomedical announces psilocybin longevity research program
TipRanks · 11/25 12:15
Psyence BioMed Launches Psilocybin Longevity Research Program
Reuters · 11/25 12:11
Weekly Report: what happened at PBM last week (1117-1121)?
Weekly Report · 11/24 10:32
More
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBM stock methods without spending real money on the virtual paper trading platform.